Introduction: Tubercular meningitis (TBM) is an important health issue, particularly in developing countries. There are several factors which are responsible for complications. Determination and modification of such risk factors are important to manage the cases.
INTRODUCTION
TBM is a serious public health problem , particularly in immunocompromised persons. It is estimated that more than 1.5 million people died from tuberculosis in a year [1] . Tubercular meningeal involvement occur in about 1% patients with active tuberculosis [2] . Neurological and systemic complication are important cause of mortality and morbidity in TBM. 50% cases of TBM results with complication or death even with treatment with anti tubercular drugs [3] . Old age, alcoholism, immune disorders, malignancy, diabetes, intravenous drug user, splenectomy, immunosuppressive drugs, smoking, with pulmonary involvement, treatment delay, advanced stage of TBM on admission-may be the factors that causes more complication. Other investigational parameters like high protein & lactate in CSF, hydrocephalous are associated with increased risk [4] . Our aim of this study is to determine the risk factors and its relation with complications [5] . This study may be helpful for the clinician and to the community regarding management of TBM.
METHODS
We performed the study at Murshidabad Medical College(MMC) during the period august 2017 to December of 2017 and included total 50 cases randomly. It is the catchment area of surrounding four districts of West Bengal and Jharkhand. Cases were either diagnosed at MMC or came for follow up after diagnosed out side. It is a retrospective, observational, analytical study. Inclusion criteria were: (1) diagnosed cases of TBM, (2) age more than 18 years at the time of diagnosis & (3) neurological complications associated with TBM within 6 months follow up. Exclusion criteria were: (1) Unwilling patients and (2) iatrogenic complications from this study. We noted details history, examined clinically and adviced proper investigations in each case. We collected all data for age, sex, socioeconomic status, educational back ground, nutritional status, personal habits(smoking, alcohol intake, IV drug use), occupation(type of job), glycemic status, renal function, liver function, autoimmune disorders(lupus etc.), HIV infection, malignant conditions, immunosuppressive drugs, major operation in the past (splenectomy etc.), treatment delay(interval between first symptoms and specific treatment), stage of disease at presentation(MRC-Medical Research Council, 1=no definite neurological symptoms plus minus meningism, 2=signs of meningeal irritation, clouding of consciousness, focal neurological signs-hemiparesis, cranial nerve palsy, 3= severe clouding of consciousness or delirium, convulsion, serious neurological signs such as hemiplegia, paraplegia, involuntary movements), CSF protein, cell count, CBNAAT, ADA [6] .We analysed data in respect to risk factors TBM uncomplicated, TBM complicated cases. Glasgow outcome scale were used to asses outcome(1=death, 2= persistent vegetative state,3= severe disability, dependent, 4=moderate disability, independent, 5= good, normal life [7] .
RESULTS
Among 50 patients in the study group 90% (n=45) were in low socioeconomic group with poor educational status, 60% (n=30) were female, 54% (n=27) were malnourished. History of contact with known tuberculosis patients was positive in 30%(n=15) cases. Vaccination with BCG was not known in 68%(n=34) cases, most of them were in older age group. Among 50 patients following data were found -smoker 30%(n=15), alcoholic 18%(n=9), heavy worker 10%(n=5), diabetic 18% (n=9), HIV+ 14%(n=7), systemic lupus 2%(n=1), vagotomy 2%(n=1), splenectomy 2%(n=1). Presentation according to MRC staging were-stage 1=50%(n=25), stage 2= 40% (n=20), stage 3= 10%(n=5). Treatment delay was found as early delay(<20 days) 40%(n=20) cases, late delay (>20 days) 60%(n=30) cases. 8%(n=4) patients were affected by pulmonary tuberculosis previously. Signs of meningial irritation was found in 90%(n=45) cases, hemiparesis 14% (n=7) cases, cranial nerve palsy in 16% (n=8) cases, seizure in 12%(n=6) cases, cognitive impairment in 18%(n=9) cases, hearing loss in 4%(n=2) cases, hemiataxia 2%(n=1) cases, cortical blindness in 25(n=1) cases, myelo radiculopathy/ paraparesis in 4%(n=2) cases [ Table 1 ]. Evidences of tuberculosis were found in 42%(n=21) cases and miliary mottling in 18%(n=9) cases. CSF cell count(cell/micro L) was up to100 in 40%(n=20), 101 to 400 in 40% (n=20), more than 400 in20%(n=10) cases. CSF protein(mg/dl) raised upto 100 in 50%(n=25) cases, 101 to 400 in 40%(n=20) caese, more than 400 in 10%(n=5) cases. CSF glucose (mg/dl) was found <20 in 6%(n=3), 21 to 60 in 72%(n=36), >60 in 22%(n=11) cases. CSF ADA(IU/L) was 10 to 30 in 70%(n=35) cases and >30 in 30%(n=15) cases. Abnormal neuroimaging (CT/MRI Brain) in the form of meningeal enhancement in 78% (n=39) cases, hydrocephalous 18%(n=9) cases, infarct in 14%(n=7) cases, tuberculoma in 6%(n=3) cases. Among 7 infarct cases basal ganglia involved in 5 cases, with cortical involvement in 2 cases. Median age of stroke was 37 years. Outcome was determined by Glasgow outcome scale-GOS 1= not included in this study, GOS 2 =2%(n=1), GOS 3=16%(n=8), GOS 4=44%(n=22), GOS 5 =38%(n=19). Risk factor analysis with neurological complications with no neurological complications are shown in table 2.
DISCUSSION
Tubercular meningitis is a medical emergency. Early diagnosis, proper treatment, handling of risk factors are most important to reach ultimate goal. Most of the patients in age group <40 years are susceptible to end in nervous system complications. Virmani et al obsevered 35.5% cases was in 21 to 30 years age group [8] . In our study females were more sufferer (60%) and prone to develop neurological complications. But Gambhir et al found more incidences in Males.
[9] Seizure was found in12% cases which was consistent with study done by Virmani [8] . Past history of tuberculosis was found in 16% cases, whereas in Ahuja et al study, it was 10% [10] . In our study cranial nerve palsy was found in 16% cases but Khatua et al found it in 50% cases in 1961, Virman et al found in 15.4% cases [11, 8] . Stroke in TBM are mostly ischemic, often with ischemic conversion, involves deep penetrating arteries: the basal ganglion, internal capsule, thalamus. Cortical and sub cortical infarct are not uncommon [12] . In our study 18% cases were suffered from stroke but Anderson et al found it in 33% cases [13] . Ribera et al found higher CSF ADA (15.7U/L) in TBM cases [14] . CSF protein level also raised in TBM and has significant correlation with CSF ADA [15] . BCG vaccination has protection against TBM, disseminated TB, military TB [16] . In our study 68% cases had no definite history of BCG vaccination. Several studies showed role BCG vaccinate in reducing mortality from TBM [17] . Late delay in treatment was found in 60% cases. In a Taiwan study 47.6% patients experienced delay in initiating treatment [4] . MRC stage 3 was in 10% cases in our adult study but it was 62% in another paediatric study. [18] GCS, raised ICT, hydrocephalous are important predictors of mortality [19] . HIV infected patients are at increased risk to develop TBM [20] . In our study 4% cases were HIV positive. Clinical presentation, outcome do not seem to be altered in HIV positive cases [21] . We found hydrocephalous in 18% cases, in other study it was 12% [22] .
Hydrocephalous was found in 18% cases in another study and predicted as poor outcome [23] . Old age, advanced stage on admission, hydrocephalous, positive TB culture in CSF are the factors associated with poor prognosis of TBM [24] . In our study we found age <40 years, female sex, long delay in treatment, alcoholism, poor socioeconomic and nutritional status, previous tubercular infection, MRS stage 3, diabetes, CSF cell count and protein >400, ADA >30, hydrocephalous, abnormal chest x ray as important risk factors for neurogenic complication in TBM.
CONCLUSION
Complications of tubercular meningitis patient having several risk factor is more than patient having no risk facor. 
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